Koyfin Home > Directory > Health Care > Aduro Biotech > Gross Profit

Aduro Biotech Gross Profit Chart (ADRO)

Aduro Biotech annual/quarterly Gross Profit from 2013 to 2020. Gross profit is the profit after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Gross profit = Revenue - Cost of Goods Sold.
  • Aduro Biotech Gross Profit for the quarter ending June 06, 2020 was $-6m a -93.55% increase of 5m year over year
  • Aduro Biotech Gross Profit for the last 12 months ending June 06, 2020 was $-31m a -65.78% increase of 20m year over year
  • Aduro Biotech Annual Gross Profit for 2019 was $-49m a -24.97% increase of 12m from 2018
  • Aduro Biotech Annual Gross Profit for 2018 was $-61m a -18.76% increase of 11m from 2017
  • Aduro Biotech Annual Gross Profit for 2017 was $-72m a 48.66% decrease of -35m from 2016
Other Income Statement Metrics:
  • Aduro Biotech EBITDA for the quarter ending December 12, 2018 was $-23m a 9.58% decrease of -2m year over year
  • Aduro Biotech Net Income for the quarter ending December 12, 2018 was $-26m a 18.34% decrease of -5m year over year
  • Aduro Biotech Total Revenue for the quarter ending December 12, 2018 was $3m a -140.28% decrease of -4m year over year
View Chart On Koyfin

Quarterly ADRO Gross Profit Data

06/2020$-6m
03/2020$-2m
12/2019$-11m
09/2019$-11m
06/2019$-12m
03/2019$-14m
12/2018$-15m
09/2018$-16m
06/2018$-17m
03/2018$-14m

Annual ADRO Gross Profit Data

2019$-49m
2018$-61m
2017$-72m
2016$-37m
2015$14m
2014$-10m
2013$-10m
2012$-7m